The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Growth recovery in patients with BRAF altered pediatric low-grade gliomas (LGG) after discontinuation of tovorafenib.
 
Cassie Kline
Research Funding - Bristol-Myers Squibb (Inst); Chimerix (Inst); Curis (Inst); Day One Therapeutics (Inst); Ipsen (Inst); Kazia Therapeutics (Inst); Midatech Pharma (Inst); Regeneron (Inst)
 
Karen Wright
Research Funding - Day One Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Day One Biopharmaceuticals
 
Lindsay Kilburn
Employment - Children's National Hospital; Kaiser Permanente (I)
Stock and Other Ownership Interests - Onconova Therapeutics (I)
Consulting or Advisory Role - Blueprint Medicines
Research Funding - Chimerix (Inst); Day One Biopharmaceuticals (Inst); Novartis (Inst); Recursion Pharmaceuticals (Inst); Regeneron (Inst); SonaCare Medical (Inst); SpringWorks Therapeutics (Inst)
 
Susan Chi
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb/Roche; Epizyme
Travel, Accommodations, Expenses - Epizyme
 
Daniel Landi
Speakers' Bureau - Day One Biopharmaceuticals
 
Jasper van der Lugt
No Relationships to Disclose
 
Sarah Leary
Research Funding - Day One Therapeutics (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); PTC Therapeutics (Inst); Regeneron (Inst)
 
Mohamed Abdelbaki
Consulting or Advisory Role - Day One Biopharmaceuticals
Speakers' Bureau - Day One Biopharmaceuticals
Research Funding - Novartis
 
Simon Bailey
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Lilly
 
Dong-Anh Khuong-Quang
No Relationships to Disclose
 
Elias Sayour
Consulting or Advisory Role - Siren Biotechnology
Patents, Royalties, Other Intellectual Property - iOncologi
 
Olaf Witt
Honoraria - Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; BMS; Day One Therapeutics; Janssen Research & Development (Inst); Merck KGaA; Novartis; Roche; SK Life Sciences
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Day One Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Research & Development (Inst); Lilly (Inst); Loxo (Inst); Loxo/Bayer (Inst); Novartis (Inst); PreComb Therapeutics (Inst); Roche Pharma AG (Inst)
 
Pablo Hernáiz Driever
Consulting or Advisory Role - Alexion Pharmaceuticals (Inst); Bayer (Inst); Ipsen
 
Valérie Larouche
Consulting or Advisory Role - Alexion Pharmaceuticals
 
Ashley Bailey-Torres
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Lindsey Ott
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Jiaheng Qiu
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Lisa McLeod
Employment - Day One Biopharmaceuticals
Stock and Other Ownership Interests - Day One Biopharmaceuticals
 
Sabine Mueller
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Chimerix (Inst); Curis (Inst); Day One Biopharmaceuticals (Inst); Gilead Sciences (Inst); Kazia Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)